脾胃培源方对脾胃虚弱型慢性萎缩性胃炎的临床疗效及理化指标的影响

李学军; 吴婧; 陈亮亮; 刘礼梅; 孙建; 夏建国; 金月萍; 叶莎莎; 李永帅

doi:10.3969/j.issn.1671-038X.2016.07.14

脾胃培源方对脾胃虚弱型慢性萎缩性胃炎的临床疗效及理化指标的影响

- 安徽中医药大学第二附属医院脾胃病科, 安徽合肥 230061
基金项目:
安徽省卫生厅中医药科研课题项目计划(No:2014zy11)

详细信息

作者简介:
李学军,男,主任医师,硕士生导师

通讯作者: 李学军,E-mail:lixuejun0308@126.com

中图分类号: R573.3

收稿日期: 2016-01-13

Effect of Piwei Peiyuan Decoction on chronic atrophic gastritis with the type of spleen-stomach deficiency and its effect on physicochemical index

- Department of Gastroenterology, the second Affiliated Hospital of Anhui University of TCM, Hefei 230061, China

More Information

Corresponding author: LI Xue-jun, E-mail: lixuejun0308@126.com

Received Date: 13 January 2016

摘要

摘要: [目的]观察脾胃培源方对脾胃虚弱型慢性萎缩性胃炎(CAG)的临床疗效及理化指标的影响,为临床治疗提供参考依据。[方法]将60例脾胃虚弱型CAG患者,随机分为治疗组和对照组,各30例。治疗组予中药脾胃培源方内服,对照组予中成药胃复春口服,3个月为1个疗程。治疗1个疗程后,对2组临床疗效、血清胃蛋白酶原数值及病理积分情况进行评价。[结果]治疗组总有效率为96.67%,对照组总有效率为76.67%,治疗组优于对照组,差异有统计学意义(P＜0.05)。2组治疗后血清胃蛋白酶原(PG)数值都得到改善,与治疗前比较,差异有统计学意义(P＜0.01,P＜0.05),与对照组比较差异有统计学意义(P＜0.05)。2组治疗后病理量化积分均下降,与治疗前比较,差异有统计学意义(P＜0.05),与对照组比较疗效相当,差异无统计学意义(P＞0.05)。[结论]脾胃培源方能有效缓解脾胃虚弱型CAG患者的临床症状,明显改善理化指标,临床疗效安全可靠,值得临床上推广与应用。
- 脾胃培源方 /
- 慢性萎缩性胃炎 /
- 脾胃虚弱 /
- 临床疗效 /
- 病理量化积分 /
- 血清胃蛋白酶原
Abstract: [Objective] To observe the therapeutic effects and the influence of laboratory data of Piwei Peiyuan decoction(PPD)for the spleen-stomach deficiency type of chronic atrophic gastritis,so as to provide a reference for the clinical treatment.[Methods] A total of 60 chronic atrophic gastritis patients with the type of spleen-stomach deficiency were randomly divided into treatment group and control group randomly.Each group contained 30 cases.The patients in the treatment group were treated with PPD,while the control group with Weifuchun tablets.The treatment course was three months in each group.After one course,the clinical efficacy level,pathological integration and serum pepsinogen level were compared respectively.[Results] The overall clinical effectiveness rate was 96.67% in the treatment group,which was higher than 76.67% in the control group.The difference showed statistical significance(P＜0.05).After the treatment,serum pepsinogen level in the two groups all improved(P＜0.01,P＜0.05).Compared with the control group,the serum pepsinogen level significantly improved(P＜0.05).The pathological integration in the two groups were lower than before the treatment(P＜0.05),with statistical significance.The difference between the two groups in pathological integration had no statistical significance(P＞0.05).[Conclusion] PPD showed good clinical effect in treating chronic atrophic gastritis of spleen-stomach deficiency with the laboratory data improved significantly.PPD is worthy of clinical promotion and application due to its efficacy and safety.
- Piwei Peiyuan decoction(PPD) /
- chronic atrophic gastritis /
- spleen-stomach deficiency /
- clinical effect /
- pathological integration /
- pepsinogen

HTML全文

参考文献(8)

[1]	林根友, 谢海萍.慢性萎缩性胃炎胃镜下不同病理改变与幽门螺杆菌感染的关系[J].中华医院感染学杂志, 2013, 23(10):2400-2402.
[2]	沈利娟, 韦玉娜.消痞和胃方治疗慢性萎缩性胃炎45例[J].中国实验方剂学杂志, 2015, 21(7):191-194.
[3]	中华医学会消化病分会.中国慢性胃炎共识意见[J].胃肠病学, 2013, 18(1):24-31.
[4]	郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社, 2002:124-129.
[5]	中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见(2009, 深圳)[J].中国中西医结合消化杂志, 2010, 18(5):345-349.
[6]	杨沈秋, 张禹, 潘祥宾, 等.养胃散治疗慢性萎缩性胃炎胃阴不足证疗效观察[J].中医药学报, 2012, 40(3):164-165.
[7]	陈洁, 朱明辉, 彭岚, 等.血清胃蛋白酶原水平与慢性萎缩性胃炎的相关性分析[J].中国卫生检验杂志, 2015, 25(21):3649-3650.
[8]	郑逢民, 郑乐乐, 郑中坚.消痞愈萎汤联合胃复春片治疗慢性萎缩性胃炎伴胃黏膜肠上皮化生或异型增生64例临床观察[J].中医杂志, 2015, 56(4):311-314.